Mastroiacovo–De Rosa–Satta syndrome

Mastroiacovo–De Rosa–Satta Syndrome

Mastroiacovo–De Rosa–Satta syndrome is a rare genetic disorder characterized by a distinct set of congenital anomalies and clinical features. It was first described by Mastroiacovo, De Rosa, and Satta, who identified the syndrome in a small number of patients exhibiting similar phenotypic characteristics.

Clinical Features

Patients with Mastroiacovo–De Rosa–Satta syndrome typically present with a combination of the following features:

• Craniofacial anomalies: These may include microcephaly, hypertelorism, and a broad nasal bridge.
• Skeletal abnormalities: Affected individuals may have short stature, brachydactyly, and other limb malformations.
• Neurological manifestations: Developmental delay and intellectual disability are common, with some patients experiencing seizures.
• Cardiac defects: Congenital heart defects such as ventricular septal defect may be present.
• Other anomalies: Additional features can include renal anomalies, gastrointestinal malformations, and hearing loss.

Genetics

Mastroiacovo–De Rosa–Satta syndrome is believed to follow an autosomal recessive inheritance pattern, although the specific genetic mutation responsible has not been definitively identified. Research is ongoing to determine the exact genetic cause and to better understand the molecular mechanisms underlying the syndrome.

Diagnosis

Diagnosis of Mastroiacovo–De Rosa–Satta syndrome is primarily clinical, based on the presence of characteristic features. Genetic testing may be used to rule out other conditions with overlapping symptoms. A multidisciplinary approach involving geneticists, neurologists, cardiologists, and other specialists is often necessary for comprehensive evaluation and management.

Management

There is currently no cure for Mastroiacovo–De Rosa–Satta syndrome, and treatment is symptomatic and supportive. Management strategies may include:

• Developmental support: Early intervention programs and special education services can help address developmental delays.
• Medical management: Treatment of seizures, cardiac defects, and other medical issues as they arise.
• Surgical interventions: Corrective surgeries may be necessary for certain congenital anomalies.

Prognosis

The prognosis for individuals with Mastroiacovo–De Rosa–Satta syndrome varies depending on the severity of symptoms and the presence of associated complications. Early diagnosis and intervention can improve quality of life and functional outcomes.

Also see

• Genetic disorders
• Congenital anomalies
• Syndromes
• Rare diseases

NIH genetic and rare disease info

• NIH info on Mastroiacovo–De Rosa–Satta syndrome

Mastroiacovo–De Rosa–Satta syndrome is a rare disease.